Adenosine dialdehyde analogs I: Regioselective synthesis of adenosine monoaldehydes

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 12, 1996, Pages 1381-1386

  Neenan, John P ^a   Opitz, Sumittada M ^a   Cooke, Charles L ^a   Ussery, Michael A ^b   Morrill, Terence C ^a   Eckel, Linda M ^a  

^a ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3' MONOALDEHYDE; ADENOSINE DIALDEHYDE; ADENOSINE DIALDEHYDE DERIVATIVE; ADENOSYLHOMOCYSTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN L 929; COMPETITIVE INHIBITION; DRUG SYNTHESIS; ENZYME INHIBITION; MOUSE; NONHUMAN; REDUCTION; VACCINIA VIRUS; VERO CELL; VESICULAR STOMATITIS VIRUS;

EID: 0029890466     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00234-X     Document Type: Article

References (28)

1. Kaufman, J.; Mittle, A. Cancer Chemother. Rep. Pt. 1 1975, 59, 1007.
2. Kinnamon, K. E.; Steck, E. A.; Rune, D. S. Antimicrob. Agents Chemother. 1979, 15, 157.
3. Neenan, J. P.; Schram, K. H. Abstracts of Papers, 185th National Meeting of the American Chemical Society, Seattle, WA, American Chemical Society: Washington, D. C., 1983; MEDI-17.
4. Dvonch, W.; Fletcher, W.; Gregory, E-M.; Healy, H.; Warren, G. H.; Alburn, H. E. Cancer Res. 1966, 26, 2386.
5. Keller, B. T.; Borchardt, R. T. Fed. Proc., Fed. Am. Soc. Exp. Biol. 1983, 42, 2139.
6. Keller, B. T.; Borchardt, R. T. Molec. Pharmac. 1987, 31, 485.
7. Neenan, J. P.; Opitz, S. M.; Borges, K. M.; Grinnell, J. D.; Canonico, P. G.; Ussery, M. A. Abstracts of Papers, 192nd National Meeting of the American Chemical Society, Anaheim, CA, American Chemical Society: Washington, D. C., 1986; MEDI-87.
8. Cysyk, R. L.; Adamson, R. H. Cancer Treatment Reports 1976, 60, 563.
9. Kyhm, J. X.; Cohn, W. E. J. Amer. Chem. Soc. 1960, 82, 6380.
10. 2O (compounds 2 and 6, respectively).
11. 2-of THF).
12. Nemec, J.; Rhoades, J. M. Nucleosides and Nucleotides 1983, 2, 99.
13. 2-2′).
14. 28
15. Grant, A. J.; Lerner, L. M. J. Med. Chem. 1980, 23, 795.
16. Howarth, O.; Jones, A. S.; Walker, R. T.; Wyatt, P. G. J. Chem. Soc., Perkins Trans. II 1984, 261.
17. 2O) δ 8.37-8.16 (m, 2 H; H-2 and H-8); 6.14-5.99 (m, 1 H; H-1′); 5.17-4.70 (m, 5 H; 2 H-2′, H-4′ and 2 H-5′).
18. Keller, B. T.; Borchardt, R. T. Molec. Pharmac. 1987, 31, 485.
19. De Clercq, E.; Cools, M. Biochem. Biophys. Res. Commun. 1985, 129, 306.
20. De Clercq, E. Biochem. Pharmac. 1987, 36, 2567.
21. Hoffman, J. L. Transmethylation; Usdin, E.; Borchardt, R. T.; Creveling, C. R., Eds.; Elsevier: New York, 1979; pp 181-186.
22. Palmer, J. L.; Abeles, R. H. J. Biol. Chem. 1976, 251, 5817.
23. 14C] adenosine, 54.3 mCi/mmol (New England Nuclear); and inhibitor in a final volume of 0.2 mL. The reaction was started by addition of enzyme followed by incubation at 37 °C for 2.5 min. The reaction was terminated by heating in boiling water for 2 min., followed by centrifugation. After addition of 5 μ1 each of 5 mM solutions of adenosine, inosine, and product AdoHcy as markers, aliquots (5 × 5 μ1 each) were spotted on aluminum-supported silica gel 60 F254 TLC sheets (E. Merck). Chromatograms were developed in 1-butanol : acetic acid : water (12:3:5) for 100 min. Spots containing radioactive product were visualized under UV light, cut out, and counted after addition of Scintisol fluor. Each reaction was run in duplicate. Kinetic parameters were determined by Lineweaver-Burk plots.
24. Antiviral data on compounds 1, 2, 5 and 6 were obtained from the U. S. Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
25. LeMaitre, M.; Bayard, B.; Lebleu, B. Proc. Natl. Acad. Sci., U.S.A. 1987, 84, 648.
26. Cheng, Y-C.; Neenan, J. P.; Goz, B.; Ward, D. C.; Prusoff, W. H. J. Virol. 1975, 15, 1284.
27. Hasehke, R. H.; Ordronneau, J. M.; Bunt, A. H. J. Neurochem. 1980, 35, 1431.
28. Hansske, F.; Cramer, F. Carbohydr. Res. 1977, 54, 75.